Workflow
Regenxbio (NasdaqGS:RGNX) FY Conference Transcript
REGENXBIOREGENXBIO(US:RGNX)2025-09-09 00:32

Regenxbio (NasdaqGS:RGNX) FY Conference September 08, 2025 11:30 AM ET Company ParticipantsCurran Simpson - Board Member, President & CEOSteve Pakola - Chief Medical OfficerNoneWelcome, everyone, to this session of the Morgan Stanley Global Healthcare Conference. We're excited to have the team from REGENXBIO Inc. here. Curran, Mitch, and Steve, thanks for coming. Let me just first read a quick disclosure. For important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanl ...